Effects of repetitive transcranial magnetic stimulation on auditory hallucinations refractory to clozapine

Journal of Clinical Psychiatry

Volumn 68, Issue 10, 2007, Pages 1528-1532

  Rosa, Marina O ^a   Gattaz, Wagner F ^a   Rosa, Moacyr A ^a   Rumi, Demetrio O ^a   Tavares, Hildeberto ^a   Myczkowski, Martin ^a   Sartorelli, Maria C ^a   Rigonatti, Sergio P ^a   Elkis, Helio ^a   Cabral, Sergio B ^a   Teixeira, Manoel J ^a   Marcolin, Marco A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE;

ADULT; ARTICLE; AUDITORY HALLUCINATION; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HEADACHE; HUMAN; MALE; MENTAL PATIENT; PARALLEL DESIGN; PARIETAL LOBE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; RANDOMIZATION; TEMPORAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; VISUAL ANALOG SCALE;

EID: 35948993005     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v68n1009     Document Type: Article

References (32)

1. Beiser M, Iacono WG. An update on the epidemiology of schizophrenia. Can J Psychiatry 1990;35:657-658
2. Slade PD, Bentall RP. Sensory Deception: Towards a Scientific Analysis of Hallucinations. London, England: Slade and Bentall; 1988
3. Andreasen NC, Flaum M. Schizophrenia: the characteristic symptoms. Schizophr Bull 1991;17:27-49
4. Van Os J, Murray RM. Predictors of outcome in schizophrenia. J Clin Psychopharmacol 1998;18(2, suppl 1):2S-4S
5. Itil TM, Keskiner A, Fink M. Therapeutic studies in "therapy resistant" schizophrenic patients. Compr Psychiatry 1966;7:488-493
6. Jus A, Villeneuve A, Jus K. Therapeutic dilemma in neuroleptic-resistant psychotic disorders. In: Deniker P, Radouco-Thomas C, Villeneuve A, et al, eds. Neuropsycopharmacology, Proceedings of the Tenth Congress of CINP, Quebec, 1976. Oxford, England: Pergamon Press; 1978:331-338
7. Kane JM, Honegfeld G, Singer J. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-796
8. Tandon R, Jibson MD. Efficacy of newer generation antipsychotics in the treatment of schizophrenia. Psychoneuroendocrinology 2003 ;28(suppl 1):9-26
9. Chong SA, Remington G. Clozapine augmentation: safety and efficacy. Schizophr Bull 2000;26:421-440
10. Amsler HA, Teerenhovi L, Barth E. Agranulocitosis in patients treated with clozapine: a study of the Finnish epidemic. Acta Psychiatr Scand 1977;56:241-248
11. Kinon BJ, Kane JM, Chakos M, et al. Possible predictors of neuroleptic-resistant schizophrenic relapse: influence of negative symptoms and acute extrapyramidal side effects. Psychopharmacol Bull 1993;29:365-369
12. Hoffman RE, Boutros NN, Hu S, et al. Transcranial magnetic stimulation and auditory hallucinations in schizophrenia. Lancet 2000;355:1073-1075
13. Hoffman RE, Hawkins KA, Gueorguieva R, et al. Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry 2003;60:49-56
14. Poulet E, Brunelin J, Bediou B, et al. Slow transcranial magnetic stimulation can rapidly reduce resistant auditory hallucinations in schizophrenia. Biol Psychiatry 2005;57:188-191
15. Bentaleb LA, Beauregard P, Liddle E, et al. Cerebral activity associated with auditory verbal hallucinations: a funcional magnetic resonance imaging case study. J Psychiatry Neurosci 2002;27:110-115
16. Lennox BR, Park JSB, Medley I, et al. The functional anatomy of auditory hallucinations in schizophrenia. Psychiatry Res 2000;100:13-20
17. Izumi Y, Terao T, Ishino Y, et al. Differences in regional cerebral blood flow during musical and verbal hallucinations. Psychiatry Res 2002; 116:119-123
18. Weiss AP, Heckers S. Neuroimaging of hallucinations: a review of the literature. Psychiatry Res 1999;92:61-74
19. Hoffman RE, Cavus I. Slow transcranial magnetic stimulation, long-term depotentiation, and brain hyperexcitability disorders. Am J Psychiatry 2002;159:1093-1102
20. D'Alfonso AA, Aleman A, Kessels RP, et al. Transcranial magnetic stimulation of left auditory cortex in patients with schizophrenia: effects on hallucinations and neurocognition. J Neuropsychiatry Clin Neurosci 2002;14:77-79
21. Hoffman RE, Gueorguieva R, Hawkins KA, et al. Temporal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample. Biol Psychiatry 2005;58:97-104
22. Lee SH, Kim W, Chung YC, et al. A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations. Neurosci Lett 2005;376: 177-181
23. McIntosh AM, Sempled D, Taskerk K, et al. Transcranial magnetic stimulation for auditory hallucinations in schizophrenia. Psychiatry Res 2004;127:9-17
24. Saba G, Verdon CM, Kalalou K, et al. Transcranial magnetic stimulation in the treatment of schizophrenic symptoms: a double blind sham controlled study. J Psychiatr Res 2006;40:147-152
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
26. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P), Version 2. New York, NY: New York State Psychiatric Institute, Biometrics Research; 1996
27. Hoffman RE, Boutros NN, Berman RM, et al. Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated voices. Biol Psychiatry 1999;46:130-132
28. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale for Schizophrenia. Schizophr Bull 1987;13:261-276
29. Aitken RCB. Measurement of feelings using visual analogue scales. Proceedings of the Royal Society of Medicine 1969;62:989-996
30. Mowerman S, Siris SG. Adjunctive loxapine in a clozapine-resistant cohort of schizophrenic patients. Ann Clin Psychiatry 1996;8:193-197
31. Kupchik M, Spivak B, Mester R, et al. Combined eletroconvulsive-clozapine therapy. Clin Neuropharmacol 2000;23:14-16
32. Silbersweig DA, Stern E, Frith C, et al. A functional neuroanatomy of hallucinations in schizophrenia. Nature 1995;378:176-179